Back to Search
Start Over
Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter
- Source :
- The American journal of cardiology. 85(8)
- Publication Year :
- 2000
-
Abstract
- Dofetilide may be advantageous in terminating atrial fibrillation/atrial flutter (AFl) when there are contraindications for class I drugs (left ventricular dysfunction and/or manifest myocardial ischemia) and beta blockers. In particular, its successful outcome in usually drug-resistant AFl is promising and underscores the importance of selective class III action for terminating AFl.
- Subjects :
- Male
medicine.medical_specialty
Time Factors
Heart disease
medicine.medical_treatment
Dofetilide
Class iii
Antiarrhythmic agent
Double-Blind Method
Internal medicine
Atrial Fibrillation
Phenethylamines
medicine
Potassium Channel Blockers
Humans
Sinus rhythm
cardiovascular diseases
Infusions, Intravenous
Flecainide
Sulfonamides
Dose-Response Relationship, Drug
business.industry
Atrial fibrillation
Middle Aged
medicine.disease
Atrial Flutter
Anesthesia
cardiovascular system
Cardiology
Female
Safety
Cardiology and Cardiovascular Medicine
business
Anti-Arrhythmia Agents
Atrial flutter
medicine.drug
Subjects
Details
- ISSN :
- 00029149
- Volume :
- 85
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- The American journal of cardiology
- Accession number :
- edsair.doi.dedup.....9fb81976c7884c1bb09e5263a8958b95